Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors

被引:63
作者
Das, J [1 ]
Furch, JA [1 ]
Liu, CJ [1 ]
Moquin, RV [1 ]
Lin, J [1 ]
Spergel, SH [1 ]
McIntyre, KW [1 ]
Shuster, DJ [1 ]
O'Day, KD [1 ]
Penhallow, B [1 ]
Hung, CY [1 ]
Doweyko, AM [1 ]
Kamath, A [1 ]
Zhang, HJ [1 ]
Marathe, P [1 ]
Kanner, SB [1 ]
Lin, TA [1 ]
Dodd, JH [1 ]
Barrish, JC [1 ]
Wityak, J [1 ]
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA
关键词
amino-(thioaryl)thiazoles; selective Itk inhibitor;
D O I
10.1016/j.bmcl.2006.04.060
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of structurally novel aminothiazole based small molecule inhibitors of Itk were prepared to elucidate their structure-activity relationships (SARs), selectivity, and cell activity in inhibiting IL-2 secretion in a Jurkat T-cell assay. Compound 3 is identified as a potent and selective Itk inhibitor which inhibits anti-TCR antibody induced IL-2 production in mice in vivo and was previously reported to reduce lung inflammation in a mouse model of ovalbumin induced allergy/asthma. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3706 / 3712
页数:7
相关论文
共 13 条
[1]   The Tec family of tyrosine kinases in T cells, amplifiers of T cell receptor signals [J].
August, A ;
Fischer, A ;
Hao, S ;
Mueller, C ;
Ragin, M .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2002, 34 (10) :1184-1189
[2]   SYNTHESIS, TAUTOMERIC PROPERTIES, AND HYDROGEN-BONDS OF 2-HETEROARYLAMINOTHIAZOLES [J].
BODEKER, J ;
PRIES, H ;
ROSCH, D .
JOURNAL FUR PRAKTISCHE CHEMIE, 1975, 317 (06) :953-958
[3]  
CHARONNAT R, 1968, ANN PHARM FR, V26, P469
[4]   Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors [J].
Das, J ;
Liu, CJ ;
Moquin, RV ;
Lin, J ;
Furch, JA ;
Spergel, SH ;
McIntyre, KW ;
Shuster, DJ ;
O'Day, KD ;
Penhallow, B ;
Hung, CY ;
Kanner, SB ;
Lin, TA ;
Dodd, JH ;
Barrish, JC ;
Wityak, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (09) :2411-2415
[5]   Impaired NFATc translocation and failure of Th2 development in Itk-deficient CD4+ T cells [J].
Fowell, DJ ;
Shinkai, K ;
Liao, XC ;
Beebe, AM ;
Coffman, RL ;
Littman, DR ;
Locksley, RM .
IMMUNITY, 1999, 11 (04) :399-409
[6]   Signal transduction by the TCR for antigen [J].
Kane, LP ;
Lin, J ;
Weiss, A .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (03) :242-249
[7]   Altering T-cell activation by targeting the multidomain tyrosine kinase Itk [J].
Kanner, SB ;
Perez-Villar, JJ .
TRENDS IN IMMUNOLOGY, 2003, 24 (05) :249-253
[8]   Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk [J].
Liao, XC ;
Littman, DR .
IMMUNITY, 1995, 3 (06) :757-769
[9]   Selective Itk inhibitors block T-cell activation and murine lung inflammation [J].
Lin, TA ;
McIntyre, KW ;
Das, J ;
Liu, CJ ;
O'Day, KD ;
Penhallow, B ;
Hung, CY ;
Whitney, GS ;
Shuster, DJ ;
Yang, XX ;
Townsend, R ;
Postelnek, J ;
Spergel, SH ;
Lin, J ;
Moquin, RV ;
Furch, JA ;
Kamath, AV ;
Zhang, HJ ;
Marathe, PH ;
Perez-Villar, JJ ;
Doweyko, A ;
Killar, L ;
Dodd, JH ;
Barrish, JC ;
Wityak, J ;
Kanner, SB .
BIOCHEMISTRY, 2004, 43 (34) :11056-11062
[10]   Attenuation of immunological symptoms of allergic asthma in mice lacking the tyrosine kinase ITK [J].
Mueller, C ;
August, A .
JOURNAL OF IMMUNOLOGY, 2003, 170 (10) :5056-5063